Latest Diabetes: Drugs news
GLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD Complications
posted July 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
posted April 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Common Medications Tied to Older Age at Onset of Parkinson Disease
posted April 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer
posted January 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy Related Articles
Bofanglutide Linked to Meaningful Reductions in HbA1c in Adults With T2DM 
Intranasal Insulin, Empagliflozin Have Promising Effects on Cognition 
Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM 
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
